SH2D3A and COVID-19: Blocking the 5’ UTR-Nsp1 interaction, be it by a small molecule, an anti-sense RNA or other mechanisms, may resolve this tug of war to the detriment of the SARS-CoV-2 virus to help treat the devastating COVID-19.